Toll-Like Receptors and COVID-19: A Two-Faced Story with an Exciting Ending

Livia Onofrio1 Department of Clinical Medicine & Surgery, University of Naples “Federico II”, Naples, Italy

Michele Caraglia2 Department of Precision Medicine, University of Campania “L. Vanvitelli”, Naples, Italy

Gaetano Facchini3 Medical Oncology, ASL Napoli 2 Nord, “S.M. delle Grazie Hospital”, Pozzuoli (NA), Italy

Vincenzo Margherita1 Department of Clinical Medicine & Surgery, University of Naples “Federico II”, Naples, Italy

Sabino De Placido1 Department of Clinical Medicine & Surgery, University of Naples “Federico II”, Naples, Italy

Carlo Buonerba4 Regional Reference Center for Rare Tumors, Department of Oncology & Hematology, AOU Federico II of Naples, Naples, Italy;5 National Reference Center for Environmental Health, Zoo-prophylactic Institute of Southern Italy, Portici, ItalyCorrespondence[email protected]

Article: FSO605 | Received 23 May 2020, Accepted 28 May 2020, Published online: 30 Jul 2020

Cite this article
https://doi.org/10.2144/fsoa-2020-0091
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

ZhuN , ZhangD , WangWet al.A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med.382(8), 727–733 (2020).
PubMed Web of Science ®Google Scholar
WHO (2019). www.who.int/emergencies/diseases/novel-coronavirus-2019
Google Scholar
RabaanAA , Al-AhmedSH , HaqueSet al.SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Le Infez. Med.28(2), 174–184 (2020).
PubMedGoogle Scholar
WuZ , McGooganJM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA – J. Am. Med. Assoc.323(13), 1239–1242 (2020).
PubMed Web of Science ®Google Scholar
CevikM , BamfordC , HoA. COVID-19 pandemic – a focused review for clinicians. Clin. Microbiol. Infect. S1198-743X(20)30231-7 (2020). https://pubmed.ncbi.nlm.nih.gov/32344166
Web of Science ®Google Scholar
YangX , YuY , XuJet al.Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med.8(5), 475–481 (2020).
PubMed Web of Science ®Google Scholar
BeigelJH , TomashekKM , DoddLEet al.Remdesivir for the treatment of Covid-19 – preliminary report. N. Engl. J. Med. (2020) ( Epub ahead of print).
Web of Science ®Google Scholar
XuX , HanM , LiTet al.Effective treatment of severe COVID-19 patients with tocilizumab. Proc/ Natl Acad. Sci. USA117(20), 10970–10975 (2020).
PubMed Web of Science ®Google Scholar
Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) (TOCIVID-19) (2020). https://clinicaltrials.gov/ct2/show/NCT04317092
Google Scholar
FelsensteinS , HerbertJA , McNamaraPS , HedrichCM. COVID-19: immunology and treatment options. Clin. Immunol.215, 108448 (2020).
PubMed Web of Science ®Google Scholar
DiurnoF , NumisFG , PortaGet al.Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur. Rev. Med. Pharmacol. Sci.24(7), 4040–4047 (2020).
PubMed Web of Science ®Google Scholar
O'NeillLAJ , GolenbockD , BowieAG. The history of Toll-like receptors-redefining innate immunity. Nat. Rev. Immunol.13(6), 453–460 (2013).
PubMed Web of Science ®Google Scholar
KawasakiT , KawaiT. Toll-like receptor signaling pathways. Front. Immunol.5(SEP), 461 (2014).
PubMedGoogle Scholar
ImaiY , KubaK , NeelyGGet al.Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell133(2), 235–249 (2008).
PubMed Web of Science ®Google Scholar
McGonagleD , SharifK , O'ReganA , BridgewoodC. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun. Rev.19(6), 102537 (2020).
PubMed Web of Science ®Google Scholar
ZuoY , YalavarthiS , ShiHet al.Neutrophil extracellular traps in COVID-19. JCI Insight27(191), 26–27 (2020).
Google Scholar
CrouchEC , HircheTO , ShaoBet al.Myeloperoxidase-dependent inactivation of surfactant protein D in vitro and in vivo. J. Biol. Chem.285(22), 16757–16770 (2010).
PubMed Web of Science ®Google Scholar
AgassandianM , MallampalliRK. Surfactant phospholipid metabolism. Biochim. Biophys. Acta – Mol. Cell Biol. Lipids1831(3), 612–625 (2013).
Web of Science ®Google Scholar
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) (2020). https://clinicaltrials.gov/ct2/show/NCT04292899
Google Scholar
BorducchiEN , LiuJ , NkololaJPet al.Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys. Nature563(7731), 360–364 (2018).
PubMed Web of Science ®Google Scholar
JanssenHLA , BrunettoMR , KimYJet al.Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. J. Hepatol.68(3), 431–440 (2018).
PubMed Web of Science ®Google Scholar
OpalSM , LaterrePF , FrancoisBet al.Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: The ACCESS randomized trial. JAMA – J. Am. Med. Assoc.309(11), 1154–1162 (2013).
PubMed Web of Science ®Google Scholar
ShireyKA , LaiW , ScottAJet al.The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature497(7450), 498–502 (2013).
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Toll-Like Receptors and COVID-19: A Two-Faced Story with an Exciting Ending

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Toll-Like Receptors and COVID-19: A Two-Faced Story with an Exciting Ending

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date